Single & Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05603585` - Optimal Protein Supplementation and Early Exercise In Mechanically Ventilated Patients	N/A
Recruiting	`NCT06206785` - Resting Energy Expenditure in Palliative Cancer Patients
Enrolling by invitation	`NCT05028192` - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Completed	`NCT01696604` - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects	Phase 1
Recruiting	`NCT04627376` - Multimodal Program for Cancer Related Cachexia Prevention	N/A
Completed	`NCT02567773` - Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078	Phase 1
Completed	`NCT00866970` - Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia	Phase 2
Active, not recruiting	`NCT00710632` - Screening to Predict Weight Loss in Patients With Cancer	N/A
Completed	`NCT00031785` - Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer	Phase 3
Withdrawn	`NCT02017925` - Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation	N/A
Recruiting	`NCT01829880` - Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure	N/A
Completed	`NCT01692990` - Study on the Effect of Fish Oil and Appetite	Phase 0
Completed	`NCT01419145` - A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study	N/A
Terminated	`NCT00962234` - Metabolism of Lipids in Advanced Cancer	N/A
Terminated	`NCT00851448` - Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients	N/A
Completed	`NCT01015274` - Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Completed	`NCT00994669` - Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients	N/A
Completed	`NCT00972634` - Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer	N/A
Terminated	`NCT00558558` - Haelan and Nutrition in Cancer Patients	Phase 2
Terminated	`NCT00535015` - Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer	Phase 2

NCT number	NCT03392116
Study type	Interventional
Source	NGM Biopharmaceuticals, Inc
Contact
Status	Completed
Phase	Phase 1
Start date	January 29, 2018
Completion date	March 11, 2019

Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms